These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
609 related articles for article (PubMed ID: 34150845)
1. Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers. Li R; Yin YH; Ji XL; Liu X; Li JP; Qu YQ Front Mol Biosci; 2021; 8():644620. PubMed ID: 34150845 [TBL] [Abstract][Full Text] [Related]
2. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer. Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer. Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014 [TBL] [Abstract][Full Text] [Related]
4. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma. Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760 [TBL] [Abstract][Full Text] [Related]
5. Characterizing m6A modification factors and their interactions in colorectal cancer: implications for tumor subtypes and clinical outcomes. Sun W; Su Y; Zhang Z Discov Oncol; 2024 Sep; 15(1):457. PubMed ID: 39292326 [TBL] [Abstract][Full Text] [Related]
6. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome. Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909 [TBL] [Abstract][Full Text] [Related]
7. Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival. Yang J; Wu Z; Wu X; Chen S; Xia X; Zeng J Front Oncol; 2022; 12():1050288. PubMed ID: 36620557 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X Front Genet; 2022; 13():872186. PubMed ID: 35937991 [No Abstract] [Full Text] [Related]
10. Abnormal genetic and epigenetic patterns of m6A regulators associated with tumor microenvironment in colorectal cancer. Ren S; Xiao Y; Wang H; Zhao L; Li H; Wei L; Huang Y; Liu H Transl Cancer Res; 2023 Aug; 12(8):2033-2047. PubMed ID: 37701104 [TBL] [Abstract][Full Text] [Related]
11. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment. Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566 [TBL] [Abstract][Full Text] [Related]
12. The potential role of RNA N6-methyladenosine in Cancer progression. Wang T; Kong S; Tao M; Ju S Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132 [TBL] [Abstract][Full Text] [Related]
13. m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma. Li F; Wang H; Huang H; Zhang L; Wang D; Wan Y Front Genet; 2020; 11():994. PubMed ID: 33193582 [TBL] [Abstract][Full Text] [Related]
14. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma. Paramasivam A; George R; Priyadharsini JV Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868 [TBL] [Abstract][Full Text] [Related]
15. Identification of pathology-specific regulators of m Li N; Zhan X EPMA J; 2020 Sep; 11(3):485-504. PubMed ID: 32849929 [TBL] [Abstract][Full Text] [Related]
16. Gene Signature and Identification of Clinical Trait-Related m Hou J; Wang Z; Li H; Zhang H; Luo L Front Genet; 2020; 11():522. PubMed ID: 32754191 [TBL] [Abstract][Full Text] [Related]
17. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069 [TBL] [Abstract][Full Text] [Related]
18. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment. Shi Y; Wang Y; Zhang W; Niu K; Mao X; Feng K; Zhang Y Front Endocrinol (Lausanne); 2023; 14():1153802. PubMed ID: 37469973 [TBL] [Abstract][Full Text] [Related]
19. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis. Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of Expression Regulation for RNA m6A Regulators With Clinical Significance in Human Cancers. Liu X; Wang P; Teng X; Zhang Z; Song S Front Oncol; 2021; 11():624395. PubMed ID: 33718187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]